IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pivotal bioVenture Partners Investment Advisor LLC

Q1 2024 Holdings

Filed 2024-05-14 | 11 holdings | $155.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte Inc(PCVX)COM92243G108$54.2M793,03634.8%
Inozyme Pharma IncCOM45790W108$34.4M4,494,85122.1%
Arcutis Biotherapeutics Inc(ARQT)COM03969K108$20.1M2,028,00812.9%
Oculis Holding AG(OCS)ORDINARY SHARESH5870P102$19.2M1,595,91812.4%
Fusion Pharmaceuticals IncCOM36118A100$12.0M563,3857.7%
Rallybio CorpCOM75120L100$4.4M2,404,6442.9%
Exscientia PLCADS30223G102$4.4M770,5002.8%
Bolt Biotherapeutics Inc(BOLT1EUR)COM097702104$2.6M1,891,4671.7%
Vigil Neuroscience Inc(VIGL)COM92673K108$1.9M560,5951.2%
IO Biotech Inc(IOBT)COM449778109$1.5M864,1971.0%
Aligos Therapeutics IncCOM01626L105$728.4K743,2150.5%